Couverture de FDA APPROVED

FDA APPROVED

FDA APPROVED

De : Tosh Martin & Alexis Corrente
Écouter gratuitement

À propos de ce contenu audio

Husband and wife Tosh Martin and Alexis Corrente both love movies! In this series they watch two movies a week, one that was given a good review by rotten tomatoes and one that was given a bad review by rotten tomatoes. We are here to let you know if those movies are FDA APPROVED.

Copyright 2026 by Tosh Martin & Alexis Corrente
Art
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Episode 121 “Guillermo Del Toro’s Frankenstein”
      Jan 21 2026

      Tosh and Alexis finally got around to watching Guillermo del Toro's adaptation of Frankenstein. The movie currently sits at an 85% on Rotten Tomatoes, does it deserve that score? Find out now on FDA APPROVED.

      also, about an hour of this episode was cut, due to the nature of the conversation we had gotten into at about the hour and fifteen minute mark, so we do apologize if it sounds clunky. We hope you enjoy the episode.

      Afficher plus Afficher moins
      1 h et 30 min
    • Ep. 120 “One Battle After Another & Marty Supreme”
      Jan 15 2026

      Tosh and Alexis finally got around to watching two highly anticipated films of their this year. One Battle After Another, directed by Paul Thomas Anderson, and Marty Supreme, directed by Josh Safdie. One Battle has a 94% on Rotten Tomatoes and Marty Supreme has a 93% on Rotten Tomatoes. Do they deserve those scores? Find out now on FDA APPROVED

      Afficher plus Afficher moins
      3 h et 10 min
    • Ep. 119 “Caught Stealing”
      Jan 4 2026

      Tosh and Alexis finally got around to seeing Darren Aronovsky's new film Caught Stealing. It currently sits at an 86% on rotten tomatoes. Does it deserve that? Find out now on FDA APPROVED

      Afficher plus Afficher moins
      1 h et 36 min
    Aucun commentaire pour le moment